A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022)
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2023.2195547
Abstract: ABSTRACT Introduction Cyclin-dependent kinase 7 (CDK7) is a member of the CDK family of serine/threonine protein kinases and participates in the regulation of the cell cycle and mRNA transcription. CDK7 is emerging as a possible… read more here.
Keywords: review; cdk7; dependent kinase; cyclin dependent ... See more keywords